View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

More PTAB 101 Reversals - stems cells & inventory management & options trading

The PTAB Reversed an examiner’s 101 Rejection of Claims for a Method of growing stem cells in a patent application owned by CellResearch:  https://e-foia.uspto.gov/Foia/RetrievePdf?system=BPAI&flNm=fd2017002349-11-13-2018-1

 

The PTAB Reversed an examiner’s 101 Rejection of Claims for inventory management in a patent application owned by Baker Hughes:  https://e-foia.uspto.gov/Foia/RetrievePdf?system=BPAI&flNm=fd2017006294-11-13-2018-1

 

The PTAB Reversed an examiner’s 101 Rejection of Claims for a systems for options trading owned by the NYSE:  https://e-foia.uspto.gov/Foia/RetrievePdf?system=BPAI&flNm=fd2017001617-11-13-2018-1

 

But then there is this:

 

The PTAB Affirmed an examiner’s 101 Rejection of Claims in a TI patent Application for a Method of measuring velocity:  https://e-foia.uspto.gov/Foia/RetrievePdf?system=BPAI&flNm=fd2018003062-11-13-2018-1

 

Share
LundbergSteveWebsite
Author:
Principal & Chief Innovation Officer


  Back to All Resources